Vertex Pharmaceuticals (VRTX) Other Gross PP&E Adjustments: 2009-2025
Historic Other Gross PP&E Adjustments for Vertex Pharmaceuticals (VRTX) over the last 6 years, with Sep 2025 value amounting to -$1.6 billion.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments fell 14.02% to -$1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.5 billion, marking a year-over-year decrease of 842.85%. This contributed to the annual value of $771.6 million for FY2024, which is 59.61% down from last year.
- According to the latest figures from Q3 2025, Vertex Pharmaceuticals' Other Gross PP&E Adjustments is -$1.6 billion, which was down 21.16% from -$1.3 billion recorded in Q2 2025.
- Vertex Pharmaceuticals' 5-year Other Gross PP&E Adjustments high stood at $1.9 billion for Q4 2023, and its period low was -$1.6 billion during Q3 2025.
- In the last 3 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments had a median value of -$336.3 million in 2023 and averaged -$437.4 million.
- In the last 5 years, Vertex Pharmaceuticals' Other Gross PP&E Adjustments grew by 21.71% in 2021 and then slumped by 349.63% in 2024.
- Vertex Pharmaceuticals' Other Gross PP&E Adjustments (Quarterly) stood at $1.5 billion in 2021, then grew by 11.27% to $1.7 billion in 2022, then increased by 14.82% to $1.9 billion in 2023, then slumped by 59.61% to $771.6 million in 2024, then declined by 14.02% to -$1.6 billion in 2025.
- Its last three reported values are -$1.6 billion in Q3 2025, -$1.3 billion for Q2 2025, and -$1.3 billion during Q1 2025.